Blog

Best Stock Screeners for Value Investors (2026)

Last updated: 2026-10-14

By Lemma Analysis · Prices checked Oct 14, 2026 · Next review Jan 14, 2027

Disclosure: we build Lemma Analysis, a research tool for US stocks, so we are not a neutral party here. Every other tool’s price was read from its own pricing page on the date shown beside it, each tool gets its limitations as well as its strengths, ours included, and the method is set out under “How we tested”.

The short answer: for a free pass over the US market on value ratios, Finviz; for scores and a DCF worldwide at a low price, Stock Unlock; for the deepest fundamental screening and ready-made value screens, Stock Rover; to backtest a screen on point-in-time data, Portfolio123; for guru portfolios and global history, GuruFocus. Lemma Analysis, which we build, is the US-only option where each result opens on four valuation models and a Quality Score. A value screen is only half the job, so the table also says what each tool does with a result.

Six value screeners at a glance

The order is not a ranking: free tools come first, then paid ones. Each row ends on who the tool is genuinely the right choice for.

Tool	Free to use	Valuation filters	Quality filters	After the screen	Coverage	Cheapest paid plan	Best for
Finviz	Yes, delayed data	P/E, forward P/E, PEG, P/S, P/B, P/FCF, EV/EBITDA	ROE, ROA, ROI, margins, debt/equity, current ratio	Charts, news and three years of statements; no valuation model	US-listed	$39.50/mo · $299.50/yr Elite · checked Oct 14, 2026	A free first pass over the US market on the classic value ratios.
Stock Unlock	3 screener searches a week	Valuation score and ratios	Stock Scores from 1 to 5 across seven categories	An editable DCF with buy-target alerts	Global, 70+ exchanges	$9.00/mo · $90.00/yr Pro · checked Oct 14, 2026	Screening on fundamental scores worldwide and moving straight into one editable DCF.
Stock Rover	Free plan for basic research; screening is Premium, 14-day trial	300+ screening metrics; fair value	Piotroski F, Altman Z and Beneish M scores; Stock Scores	Fair value, scores, research reports and linked portfolios	US & Canada	$34.00/mo · $348.00/yr Premium · checked Oct 14, 2026	Deep fundamental screening across hundreds of metrics, starting from ready-made value screens.
Portfolio123	No — 30-day trial, no card	4,300+ factors and 430+ functions	Built from factors; expert ranking systems	Point-in-time backtests of the screen itself	US & Canada; Europe and UK as an added region	$35.00/mo · $300.00/yr Screener · checked Oct 14, 2026	Systematic investors who want to backtest a value screen before trusting it.
GuruFocus	Free account, limited	GF Value, Graham- and Lynch-style figures, ratios	GF Score; financial strength and profitability ranks	DCF calculator, valuation figures and guru holdings on the same site	Global	$549.00/yr Premium, US region · checked Oct 14, 2026	Value investors who screen alongside guru portfolios and thirty years of global data.
Lemma Analysis our product	No — part of Ultimate, 7-day free trial included	P/E and forward P/E, EV/EBIT, EV/EBITDA, FCF yield, upside to intrinsic value	Quality Score 0–10, ROIC, margins, net debt/EBITDA	Four valuation models, seven multiples against the company’s own history, the Quality Score	about three thousand US-listed companies and ADRs	$8.99/mo · $79.99/yr Ultimate · 7-day free trial included	Long-term investors who want every result to open on a valuation and a grade of the business.

Cheapest paid plan at list price in US dollars, before tax and promotions, read from each vendor’s own pricing page on the date shown.

How we chose them

A screener made the list if it met all three of these:

It filters on valuation and on quality — cash-flow and enterprise-value multiples as well as P/E, and returns, margins or debt — because a cheap price on a weak business is the trap a value screen exists to avoid.
It is sold to individual investors at a published price, not to firms on request.
It helps with the next step, or says plainly that it does not: a valuation, a score, a backtest or the research behind each result.

These are the screeners that come up most often when value investors ask which tool to use, and each answers the next step differently.

What a value screen needs

A screen for value investing asks two questions at once: is the price low relative to what the company earns, and is the company worth owning at all? Ratios answer the first; the second takes measures of the business itself.

Price against cash, not just earnings. Price to free cash flow and EV/EBITDA are harder to flatter with accounting than the P/E, and EV counts the debt.
Returns on capital. A high ROIC over several years is the clearest sign a business can reinvest at a good rate.
Debt you can survive. Net debt to EBITDA separates a cheap stock from a stock that is cheap because the lenders are nervous.
A way to the valuation. A screen narrows three thousand companies to thirty. Deciding which of the thirty is actually undervalued is an intrinsic value question, and the less distance between the list and that answer, the more of the list you will actually examine.

Our guide to using a stock screener walks through building a screen like this, filter by filter.

The six screeners, one by one

1. Finviz

Elite · $39.50/mo · $299.50/yr · checked Oct 14, 2026 · finviz.com

Best for: A free first pass over the US market on the classic value ratios.

Strengths

Every classic value ratio is a free filter, including price to free cash flow and EV/EBITDA.
Fast to use, and fifty saved screens on the free plan.
Results open straight into charts, news and the market heatmap.

Limitations

Filters are preset ranges on the free plan; typing your own threshold is part of Elite.
It stops at ratios: nothing estimates what a company on the list is worth.
Three years of statements on the free plan is short for judging a business through a cycle.

Finviz vs Lemma Analysis, row by row →

2. Stock Unlock

Pro · $9.00/mo · $90.00/yr · checked Oct 14, 2026 · stockunlock.com

Best for: Screening on fundamental scores worldwide and moving straight into one editable DCF.

Strengths

Filters on its own Stock Scores — profitability, growth, financial health, dividends, management and analysts — calibrated by industry.
One click from a result to an editable DCF, with a buy-target alert on Pro.
Global coverage at one of the lower prices on this list.

Limitations

Three screener searches a week on the free plan.
One DCF model, with an exit-multiple terminal value.
The longest score history, back thirty-five years, is reserved for its most expensive plan.

Stock Unlock vs Lemma Analysis, row by row →

3. Stock Rover

Premium · $34.00/mo · $348.00/yr · checked Oct 14, 2026 · stockrover.com

Best for: Deep fundamental screening across hundreds of metrics, starting from ready-made value screens.

Strengths

A library of more than 150 ready-made screens, including ones modelled on Buffett, Lynch and Greenblatt.
The Piotroski F-Score, Altman Z-Score and Beneish M-Score as filters, to weed out weak balance sheets and suspect accounts.
Brokerage-linked portfolios beside the research, from the cheapest paid plan.

Limitations

On Premium, fair value, Stock Scores and investor warnings cover twenty tickers a month plus the Dow 30; unlimited use is Premium Plus.
No dedicated backtesting, in Stock Rover’s own words; historical screening is Premium Plus.
The free plan is for basic research on single stocks, not for screening.

Stock Rover vs Lemma Analysis, row by row →

4. Portfolio123

Screener · $35.00/mo · $300.00/yr · checked Oct 14, 2026 · portfolio123.com

Best for: Systematic investors who want to backtest a value screen before trusting it.

Strengths

Point-in-time data, so a backtest sees only what was known on each date — five years of it on the cheapest plan.
More than 4,300 factors and 430 functions to build a screen from, and expert-built ranking systems.
Rolling screen backtests show how a rule would have behaved through different markets.

Limitations

No free plan, only a thirty-day trial.
Building your own ranking system needs a more expensive plan than the Screener one.
Built for quantitative work: a reader who wants to study one company at a time will use a fraction of it.

5. GuruFocus

Premium, US region · $549.00/yr · checked Oct 14, 2026 · gurufocus.com

Best for: Value investors who screen alongside guru portfolios and thirty years of global data.

Strengths

Value screeners for the US and for Canada, Europe, Asia and Australia–New Zealand.
Screen backtesting over the latest five years on Premium, and back to 2006 on Premium Plus.
What famous investors hold, from their 13F filings, beside every result.

Limitations

Sold yearly and by region, at one of the highest prices here.
Downloads stop at 1,000 rows on Premium and 5,000 on Premium Plus.
A very large site: the screener is one of many tools competing for your attention.

GuruFocus vs Lemma Analysis, row by row →

6. Lemma Analysis (ours)

Ultimate · $8.99/mo · $79.99/yr · 7-day free trial included

Best for: Long-term investors who want every result to open on a valuation and a grade of the business.

Strengths

Filters on a five-pillar Quality Score and on the upside to our own intrinsic value, beside the usual ratios.
Every result opens on a company page where four valuation models and the Fair Value tab are already computed.
A screen is its address: a saved link reopens the same filters, and ready-made screens are starting points you edit.

Limitations

Paid: the screener is part of Ultimate once the seven-day trial ends.
Every US-listed company and ADR above $300M in market cap — about three thousand of them, rebuilt once a day after the close. Nothing listed outside the US, and nothing smaller.
No backtesting, and no analyst consensus to screen on.

How we tested

On the check date at the top of the page we read each tool’s pricing and plan pages, its screener and its help documentation, and wrote down which value and quality filters it offers on which plan and what it does with a result. Prices are the cheapest paid plan at list price in US dollars, before tax and promotions; a plan sold only yearly shows only the yearly figure.

We did not buy the competitors’ paid plans, and we did not run the same screen through all six to compare results: their universes, data vendors and update times differ too much for one list of tickers to say which is right. GuruFocus’s screener pages could not be loaded on the check date, so its entry relies on its pricing page. Our own entry was written from the product, with its limits stated the same way. The page is re-checked every quarter.

FAQ

What is the best stock screener for value investors?

It depends on what you do after the screen. To scan cheaply for ratios, Finviz; to screen on scores and value one company with a DCF worldwide, Stock Unlock; for the deepest metric library and ready-made value screens, Stock Rover; to backtest a strategy, Portfolio123; to follow guru portfolios, GuruFocus. If you want each result to open on several valuation models and a quality grade, on US-listed companies, that is what Lemma Analysis is built for.

What filters should a value screen use?

A reasonable start is a valuation filter on cash flow (price to free cash flow or FCF yield, or EV/EBITDA), a quality filter on returns (ROIC or ROE over several years), and a solvency filter (net debt to EBITDA or debt to equity). Add a market-cap floor if you want liquid companies. Then value what remains — the screen only tells you where to look.

Is there a free value stock screener?

Finviz is the most complete free one for US stocks, and Stock Analysis gives a large free filter set including the Piotroski F-Score. Our article on the best free stock screeners compares six of them.

Can I backtest a value screen?

Portfolio123 is built for it, on point-in-time data, and GuruFocus backtests screens on its Premium plans. Stock Rover says it has no dedicated backtesting, and Lemma Analysis has none.

Does Lemma Analysis have a free screener?

No. The screener is part of Ultimate, and every new account gets seven days of it without a card. It covers about three thousand US-listed companies and ADRs; what stays free after the trial includes the Quality Score on every company.

Lemma Analysis gives independent investors both lenses in one terminal — a stock screener and an intrinsic value tool for the fundamentals, alongside price history and charts for timing.